ArticleBritish journal of cancer2007

Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma.

N Horie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.